Latest News of ZH
Ukraine war briefing: Zaporizhzhia nuclear plant employee killed in Ukrainian car bomb attack
By The Guardian |
1 day ago
Ukrainian military intelligence claims to have eliminated a 'war criminal' at a Russian-controlled nuclear power plant. An employee was killed in a car bomb attack, leading to investigations and accus...
Alzheimer's "first" achieved with drug that hits hotspots
By Newsweek |
1 day ago
A new compound, RI-AG03, has shown promise in preventing harmful tau protein clumping linked to Alzheimer's in lab experiments. The drug extended lifespan in fruit fly models and human cells, offering...
New law meant to protect people with Alzheimer's, other dementias
By CBS News |
2 days ago
A new law in Florida aims to protect individuals with Alzheimer's who may become lost or confused. The law mandates training for law enforcement officers on handling situations involving people with d...
-
'One-of-a-kind' new Alzheimer's drug shows promise: 'An exciting...
By New York Post | 3 days agoA new drug targeting toxic proteins in the brain shows promise in treating Alzheimer's disease. Researchers developed RI-AG03 to prevent tau protein clumping, a key factor in Alzheimer's progression. ...
-
Alzheimer's development as cellular cleaners offer hope for new treatments
By Newsweek | 5 days agoResearchers have discovered a new method to potentially treat Alzheimer's disease by activating the brain's cellular clean-up process in mouse models, leading to improved memory and cognitive function...
-
ZCMD Stock Price | Zhongchao Inc. Stock Quote (U.S.: Nasdaq) | MarketWatch
By MarketWatch | 5 days agoZhongchao, Inc. is a holding company in Shanghai, China, providing healthcare information, education, and training services through online and onsite platforms. Established in 2019, it operates under ...
-
Crypto Billionaire Zhao Vows More Tech Investment After Leaving US Custody
By Yahoo! Finance | 6 days agoChangpeng Zhao, founder of Binance, plans to continue investing in blockchain, AI, and biotech after his release from US custody. He emphasizes impact over returns and is focusing on philanthropy and ...
-
Jim Cramer Reports That Eli Lilly and Company (LLY)'s Donanemab Was Approved in Japan For Treating Early Symptomatic Alzheimer's Disease
By Yahoo! Finance | 1 week agoJim Cramer shared early investment experiences and the importance of starting young in the stock market. Eli Lilly & Company (LLY) stands out for its strong financial performance and innovative drug l...
-
Absence of Black Box Warning For Bristol Myers' Schizophrenia Treatment Could Enhance Alzheimer's Psychosis Potential
By Yahoo! Finance | 1 week agoFDA approved Bristol Myers Squibb's Cobenfy for schizophrenia in adults, without a boxed warning, signaling a positive outlook. Analysts project high sales for Cobenfy in treating Alzheimer's psychosi...
-
Binance founder Changpeng Zhao set for release after four-month prison sentence: CNBC Crypto World
By CNBC | 1 week agoCNBC Crypto World offers viewers the latest news and trading updates from digital currency markets, along with high-profile interviews and unique stories from the crypto industry. Kristin Smith from B...
-
Exclusive-Shanghai, Shenzhen to lift key home purchase curbs to boost market, sources say
By Yahoo! Finance | 1 week agoShanghai and Shenzhen are set to lift home purchase restrictions to attract buyers and revive their real estate markets. The changes aim to allow people from all over China to buy homes in these citie...
-
Sauber's 2025 second seat options: Valtteri Bottas, Zhou Guanyu or a young talent?
By The New York Times | 1 week agoThe Formula One driver market is heating up as teams finalize their lineups for the 2025 season. Sauber, now Audi, faces a decision on its second driver seat, weighing experience against young talent....
-
Credit Agricole Is Said to Be in Talks to Invest in Guangzhou Auto Unit
By Yahoo! Finance | 1 week agoCredit Agricole SA is in advanced talks to invest in Guangzhou Automobile Group Co.'s financial leasing unit to tap into China's electric-vehicle market....
-
Eli Lilly Gets Japan OK for Kisunla Alzheimer's Disease Drug
By MarketWatch | 1 week agoEli Lilly's Kisunla has been approved in Japan for early symptomatic Alzheimer's. The drug, also approved in the US, is an antibody given as a monthly infusion that has shown to slow the progression o...
-
Eli Lilly's Alzheimer's drug approved in Japan
By Yahoo! Finance | 1 week agoJapan's health ministry approved Eli Lilly's drug donanemab for Alzheimer's disease, offering a new treatment option. The drug, already approved in the U.S., targets the beta-amyloid protein. Despite ...